4D Molecular Therapeutics(FDMT) - 2023 Q1 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) 4D Molecular Therapeutics, Inc. (Exact name of registrant as specified in its Charter) Delaware 47-3506994 (State or other jurisdiction of incorporation or organization) 5858 Horton Street #455 Emeryville, CA 94608 (I.R.S. Employer Identification No.) (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (510) 505-2680 Securities registered pursuant to Section 12(b) ...